发明名称 Hematological assay
摘要 A hematological assay is described in which the blood coagulation potential of a body fluid is assessed by reacting a sample of the body fluid with an amount of an activator reagent comprising: (a) a predetermined amount of factor Xa or a hematologically equivalent mutant thereof, and (b) a predetermined amount of factor Va, a hematologically equivalent mutant thereof or an enzyme activating endogenous factor V, (c) (optionally) phospholipids. The reagent may be dry (e.g. lyophilised) or in an aqueous solution preferably buffered to a pH from 6 to 10 (preferably 7 to 8), if desired incubating, if necessary inducing coagulation by the addition of one or more coagulation accelerants such as calcium chloride, and establishing a value indicative of the coagulation potential, e.g. by measuring the time to clotting on an optical coagulometer or through use of a chromogenic substrate. It is preferred to use at (b) factor V activator from purified Russell's Viper venom (RVV-V). An activator reagent is also described containing the components mentioned above preferably in one or more buffer solutions or in dried, e.g. lyophilised form.
申请公布号 US6994984(B2) 申请公布日期 2006.02.07
申请号 US20020168473 申请日期 2002.08.29
申请人 PENTAPHARM AG 发明人 GEMPELER PATRIZIA MARIA;CALATZIS ANDREAS
分类号 C12Q1/37;G01N33/48;C12Q1/56;G01N33/483;G01N33/49;G01N33/86 主分类号 C12Q1/37
代理机构 代理人
主权项
地址